Committee for Advanced Therapies re-elects Christian Schneider as chair

The European Medicines Agency's Committee for Advanced Therapies (CAT) has re-elected Dr Christian Schneider as its chair for a second three-year term.

Dr Schneider, from the National Board of Health, Denmark, has been the chair of the CAT since its formation in 2009. The Committee voted for his re-election by majority yesterday, during its March plenary meeting.

Election of the Committee's vice-chair was postponed to April, as the Committee could not reach a majority on any of the three candidates.

The CAT is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines and following scientific developments in the field. Its chair and vice-chair are elected from its members for a term of three years, which may be renewed once.